|
Join us with guests Ken Blount, Ph.D., Chief Scientific Officer and Paul Plumb, Head of Clinical Operations from Rebiotix. Ken and Paul will discuss the gut microbiome and the role it plays in overall health and Rebiotix’s goal to rehabilitate the gut microbiome by utilizing their unique Microbiota Restoration Therapy™ (MRT) Platform through its extensive clinical trial program. The science behind their products, product development and how patients are an important part of helping develop new drugs will also be discussed.
|
